MLL2 anticorps (N-Term)
Aperçu rapide pour MLL2 anticorps (N-Term) (ABIN1449488)
Antigène
Voir toutes MLL2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- DSQNLAGEDK DSQ-C Remarks: The immunizing peptide was designed from NP_003473.1. Since then the sequence has changed in the databases and currently differs at two locations in NP_003473.3.
-
Purification
- Ammonium Sulphate Precipitation followed by Antigen Affinity Chromatography using the immunizing peptide
-
Immunogène
- Peptide with sequence from the N-Terminus of Human MLL2 (NP_003473.3). Genename: MLL2
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- Tris saline, pH ~7.3, 0.02 % Sodium Azide, 0.5 % BSA
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MLL2 (Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2))
-
Autre désignation
- MLL2
-
Sujet
- Synonyms: ALL1-related protein, ALR, Histone-lysine N-methyltransferase MLL2, KMT2B, Lysine N-methyltransferase 2B, Myeloid/lymphoid or mixed-lineage leukemia protein 2
-
ID gène
- 8085
-
NCBI Accession
- NP_003473
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, L'effet Warburg
Antigène
-